Skip to main content
Caplight Logo









cellvie

cellvie

Private
ZurichHealthcare & Life Scienceshttps://cellvie.bio/

Last Round

Seed

Feb 6, 2023

Total Funding Raised

$16M

Company Overview

cellvie is a biotechnology company that develops mitochondria-based therapeutic technology intended to restore cellular bioenergetics and improve organ function.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

Therapeutic Mitochondria TransplantationTMTmitochondria therapyischemia-reperfusion injuryIRIcell therapyregenerative medicinemitochondrial dysfunctionorgan transplantationoff-the-shelf cell therapyallogeneic therapygene therapy deliverykidney transplantationcellular energy metabolismGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

cellvie Comparables

Compare cellvie with similar companies based on industry and business-model similarity.

cellvie comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LUCA Science
83%
MitoSense, Inc.
78%
PAEAN Biotechnology
77%

cellvie Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 6, 2023
SeedFeb 6, 2023
SeedJan 25, 2021

Key People

Founding team and executive leadership

Alexander Schueller

Founder & CEO

Founding Team

cellvie Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors increased 133% MoM.

  • Nov 7, 2025

    Monthly visitors increased 229% MoM.

cellvie Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

cellvie Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about cellvie's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range10
Year Founded2018
Last FundingFeb 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?